Curve Biosciences announced the appointment of Dr. Amit Singal as Chief Medical Officer on April 2, 2026.134
Dr. Singal brings deep clinical expertise, translational research leadership, and decades of experience advancing patient outcomes.3
The announcement coincides with Curve Biosciences raising $40 million in funding to advance its Whole-Body Intelligence platform for chronic disease monitoring.2
Curve Biosciences is based in San Mateo, Calif., and Dallas, developing Whole-Body Blood Tests using its Whole-Body Atlas of tissue samples.2
Sources:
1. https://www.businesswire.com/newsroom?industry=1000092
2. https://www.businesswire.com/news/home/20251029166983/en/Curve-Biosciences-Raises-$40-Million-to-Bring-Whole-Body-Intelligence-to-Chronic-Disease-Monitoring
3. https://www.fidelity.com/news/article/default/202604020800BIZWIREUSPR20260402_BW405177